(PharmaNewsWire.Com, August 01, 2019 ) Meticulous Research® – leading global market research company published a research report titled “Infectious Disease Diagnostics Market by Product (Assays and Kits, Instruments, and Software & Services), Technology (Immunodiagnostics, NGS, PCR), Disease Type (Hepatitis, HIV, HPV, Tuberculosis), End User, and Geography–Global Forecast to 2025”.
According to this latest publication from Meticulous Research®, the global infectious disease diagnostics market is expected to grow at a CAGR of 5.9% from 2018 to reach $12.88 billion by 2025. The growth of this market will be driven by factors such as increasing global prevalence of infectious diseases, growing awareness for early detection using specific diagnostic tests, growth in funding for research on infectious disease diagnostics, and shift in focus from centralized laboratories to decentralized point-of-care testing. However, lack of unfavourable and inadequate reimbursement scenario may hamper the growth of this market to a certain extent.
The global infectious disease diagnostics market study presents historical market data in terms of values, estimated current data, and forecasts for 2025-by product (assays and kits, instruments, and software & services), technology (immunodiagnostics, clinical microbiology, Polymerase Chain Reaction (PCR), isothermal nucleic acid amplification technology (INAAT), DNA sequencing & Next-Generation Sequencing (NGS), DNA microarray, and other technologies), disease type (hepatitis, HIV, hospital-acquired infections, HPV, tuberculosis, influenza, and other infectious diseases), end user hospital/clinical laboratories, reference laboratories, academics/research institutes, and other end user). The study also evaluates industry competitors and analyzes the market at regional and country level.
Scope of the Report:
Infectious Disease Diagnostics Market, by Product
Assays and Kits Instruments Software & Services
Infectious Disease Diagnostics Market, by Technology Immunodiagnostics Clinical Microbiology Polymerase Chain Reaction (PCR) Isothermal Nucleic Acid Amplification Technology (INAAT) DNA Sequencing & Next-Generation Sequencing (NGS) DNA Microarray Other Technologies
Infectious Disease Diagnostics Market, by Disease Type Hepatitis HIV Hospital-Acquired Infections HPV Tuberculosis Influenza Other Infectious Diseases
Infectious Disease Diagnostics Market, by End User Hospital/Clinical laboratories Reference Laboratories Academics/Research Institutes Other End User
Infectious Disease Diagnostics Market, by Region North America U.S. Canada Europe Germany U.K. France Rest of Europe Asia-Pacific (APAC) China Japan Rest of Asia-Pacific Latin America Middle East and Africa
This research report analyzes major geographies and provides comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, and U.K.), Asia-Pacific (China, and Japan), Latin America, and Middle East & Africa. North America commanded the largest share of the global infectious disease diagnostics market in 2017, followed by Europe and Asia Pacific. The highest share of North American region in the infectious disease diagnostics market is primarily attributed to the growing healthcare sector, increasing need to treat various infectious diseases, increasing healthcare expenditure, growing demand of point-of-care testing, increase in the research and development coupled with the development of novel advanced technologies for diagnosis, and large number of patient population.
Asia Pacific region is expected to be the fastest growing geographic market for infectious disease diagnostics market with countries, such as China, Japan, India and Singapore among others are being the largest contributors to the growth of the market. Additionally, rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage growing burden of infectious diseases, and government efforts to improve accessibility of diagnostic services are expected to equally influence the overall growth of the infectious disease diagnostics market during the forecast period.
The major players operating in the global infectious disease diagnostics market are Abbott Laboratories (U.S.), Danaher (U.S.), Bio-Rad Laboratories (U.S.), bioMérieux SA (France), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), DiaSorin S.p.A. (Italy), Meridian Bioscience, Inc. (U.S.), Quidel Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.) among others.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
